Ignite Creation Date:
2024-05-05 @ 5:08 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00399451
Status:
UNKNOWN
Last Update Posted:
2006-11-22
First Post:
2006-11-13
Brief Title:
Polidocanol Sclerotherapy of Pharynges for Obstructive Sleep Apnea OSA and Snoring SubjectsSS
Sponsor:
Liaoyang Central Hospital
Organization:
Liaoyang Central Hospital
Study Overview
Official Title:
Preliminary Study on Submucous Sclerosis of Pharynges With 1 Polidocanol to Treat Obstructive Sleep Apnea OSA Snoring Subjects SS
Status:
UNKNOWN
Status Verified Date:
2006-11
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this prospective study is to evaluate the results of polidocanol sclerotherapy of pharynx for OSAS SSto reduce pharyngeal compliance
Detailed Description:
Polidocanol submucous sclerosis in the part of pharynges with 1 polidocanol injectionThe injection should be in the retropharyngeal submucosa and lateral pharyngeal bands and lateral pharyngeal submucosa and in front submucosa of soft palateThe injection is multi-pointand each point injection is 0305mlthe total quantityeach time is not more than 5mlEvery patient have to be treated about 12 time
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| ACTRNO12606000444583 | None | None | None |